Literature DB >> 16048637

Human mtDNA haplogroups and reduced male fertility: real association or hidden population substructuring.

Luísa Pereira1, João Gonçalves, Ana Goios, Tiago Rocha, António Amorim.   

Abstract

A mitochondrial DNA (mtDNA) haplogroup association study carried out in 101 southern Portuguese males with oligozoospermia showed to be negative when comparing with a geographically matching control sample. Misleading positive association signs were however obtained when using other control samples from the same country. This shows that mtDNA population substructure can also introduce spurious signs in haplogroup association studies, as previously reported for Y-chromosome. However, our data do not exclude the probability that a particular mtDNA mutation contributes significantly to the reduction of sperm production, but indeed precludes the hypothesis of a significant association between such a mutation and specific haplogroup.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16048637     DOI: 10.1111/j.1365-2605.2005.00539.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  11 in total

1.  mtDNA single macrodeletions associated with myopathies: absence of haplogroup-related increased risk.

Authors:  A Goios; C Nogueira; C Pereira; L Vilarinho; A Amorim; L Pereira
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

2.  Specificity of mtDNA-directed PCR-influence of NUclear MTDNA insertion (NUMT) contamination in routine samples and techniques.

Authors:  Ana Goios; Lourdes Prieto; António Amorim; Luísa Pereira
Journal:  Int J Legal Med       Date:  2007-09-14       Impact factor: 2.686

3.  Phylogenetic and population-based approaches to mitogenome variation do not support association with male infertility.

Authors:  Alberto Gómez-Carballa; Jacobo Pardo-Seco; Federico Martinón-Torres; Antonio Salas
Journal:  J Hum Genet       Date:  2016-12-01       Impact factor: 3.172

4.  Mitochondrial haplogroups and control region polymorphisms are not associated with prostate cancer in Middle European Caucasians.

Authors:  Edith E Mueller; Waltraud Eder; Johannes A Mayr; Bernhard Paulweber; Wolfgang Sperl; Wolfgang Horninger; Helmut Klocker; Barbara Kofler
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

5.  Mitochondrial haplogroups and control region polymorphisms in age-related macular degeneration: a case-control study.

Authors:  Edith E Mueller; Elena Schaier; Susanne M Brunner; Waltraud Eder; Johannes A Mayr; Stefan F Egger; Christian Nischler; Hannes Oberkofler; Herbert A Reitsamer; Wolfgang Patsch; Wolfgang Sperl; Barbara Kofler
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

6.  Identifying potential pitfalls in interpreting mitochondrial DNA mutations of male infertility cases.

Authors:  Malliya Gounder Palanichamy; Ya-Ping Zhang
Journal:  Indian J Med Res       Date:  2011-10       Impact factor: 2.375

7.  Associations between male infertility and ancestry in South Americans: a case control study.

Authors:  Maria Fernanda Skowronek; Tatiana Velazquez; Patricia Mut; Gonzalo Figueiro; Monica Sans; Bernardo Bertoni; Rossana Sapiro
Journal:  BMC Med Genet       Date:  2017-07-26       Impact factor: 2.103

8.  'Infertile' studies on mitochondrial DNA variation in asthenozoospermic Tunisian men.

Authors:  Antonio Salas; Federico Martinón-Torres; Alberto Gómez-Carballa
Journal:  Biochem Biophys Rep       Date:  2016-08-11

9.  Experimental assessment of bioenergetic differences caused by the common European mitochondrial DNA haplogroups H and T.

Authors:  Taku Amo; Nagendra Yadava; Richard Oh; David G Nicholls; Martin D Brand
Journal:  Gene       Date:  2008-01-26       Impact factor: 3.688

10.  Meta-Analysis of Mitochondrial DNA Variation in the Iberian Peninsula.

Authors:  Ruth Barral-Arca; Sara Pischedda; Alberto Gómez-Carballa; Ana Pastoriza; Ana Mosquera-Miguel; Manuel López-Soto; Federico Martinón-Torres; Vanesa Álvarez-Iglesias; Antonio Salas
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.